BSAC Spring Conference

Reigniting the AMR agenda

THIS CONFERENCE IS CPD ACCREDITED AND WILL BE AVAILABLE UNTIL 10 NOVEMBER 2022

HELD 10-11 MAY 2022. REGISTER NOW TO ACCESS THE RECORDED CONTENT

Karen Gallant

CARB-X Deputy Executive, Director, School of Law, Boston University

Karen Gallant is an internationally experienced pharma R&D and business development executive. During her time in business development at AstraZeneca, she was integral to the building of a rich pipeline of products for treating serious bacterial infections through partnerships, in-licensing and M&A. Prior to joining AZ, she spent several years leading global project teams to deliver innovative medicines across a number of therapeutic areas at Novartis. She serves as a mentor to start-ups through the MassConnect program. She has a PhD in Pharmacology with a specialty in Toxicology.

Top